IGF2BP1 and colorectal carcinoma: Our study also revealed that the overall interactome of IGF2BP1 decreased significantly in response to Wnt-blockade in CRC cells, with a major reduction in the enrichment of IGF2BP1 binding regions within the 3′UTR and 5′UTR of target mRNA.